Vilin Bio Med Ltd
Incorporated in 2005, Vilin Bio Med Ltd is in the business of manufacturing and selling of pharmaceutical products[1]
- Market Cap ₹ 29.4 Cr.
- Current Price ₹ 21.0
- High / Low ₹ 30.4 / 15.4
- Stock P/E
- Book Value ₹ 16.5
- Dividend Yield 0.00 %
- ROCE 4.51 %
- ROE 0.95 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 184 to 131 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 4.34% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|
| 16.62 | 11.54 | 11.21 | 12.31 | 15.80 | 12.65 | |
| 15.71 | 10.68 | 10.44 | 9.73 | 14.97 | 12.80 | |
| Operating Profit | 0.91 | 0.86 | 0.77 | 2.58 | 0.83 | -0.15 |
| OPM % | 5.48% | 7.45% | 6.87% | 20.96% | 5.25% | -1.19% |
| 0.01 | 0.00 | 0.00 | 0.02 | 0.32 | 0.44 | |
| Interest | 0.41 | 0.44 | 0.51 | 0.65 | 0.79 | 0.82 |
| Depreciation | 0.31 | 0.26 | 0.22 | 0.17 | 0.13 | 0.12 |
| Profit before tax | 0.20 | 0.16 | 0.04 | 1.78 | 0.23 | -0.65 |
| Tax % | 20.00% | 25.00% | 25.00% | 30.34% | 26.09% | |
| 0.16 | 0.12 | 0.03 | 1.25 | 0.16 | -0.49 | |
| EPS in Rs | 0.48 | 0.36 | 0.09 | 1.26 | 0.11 | -0.35 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| TTM: | -20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| TTM: | -134% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 3.30 | 3.30 | 3.30 | 9.95 | 13.95 | 13.95 |
| Reserves | 3.94 | 4.06 | 4.10 | 0.73 | 8.89 | 9.01 |
| 4.53 | 5.52 | 5.30 | 4.93 | 6.83 | 7.35 | |
| 2.24 | 1.01 | 0.86 | 2.07 | 2.73 | 3.07 | |
| Total Liabilities | 14.01 | 13.89 | 13.56 | 17.68 | 32.40 | 33.38 |
| 2.13 | 1.87 | 1.65 | 1.51 | 1.38 | 1.31 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 11.88 | 12.02 | 11.91 | 16.17 | 31.02 | 31.87 | |
| Total Assets | 14.01 | 13.89 | 13.56 | 17.68 | 32.40 | 33.38 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| -1.46 | -1.00 | 0.21 | -1.66 | -5.30 | |
| -0.02 | 0.00 | 0.00 | -0.03 | 0.32 | |
| 1.51 | 0.98 | -0.22 | 1.68 | 10.99 | |
| Net Cash Flow | 0.03 | -0.02 | -0.01 | 0.00 | 6.01 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 159.66 | 241.96 | 253.64 | 166.04 | 131.22 |
| Inventory Days | 56.13 | 83.17 | 93.82 | 44.74 | 125.41 |
| Days Payable | 49.48 | 33.11 | 26.34 | 60.49 | 54.71 |
| Cash Conversion Cycle | 166.31 | 292.03 | 321.13 | 150.28 | 201.91 |
| Working Capital Days | 210.39 | 346.66 | 360.44 | 178.50 | 229.16 |
| ROCE % | 4.87% | 4.30% | 17.17% | 4.51% |
Documents
Announcements
-
Disclosure of material issue
12 November 2024 - Vilin Bio Med Limited has informed regarding Disclosure of material issue
-
Financial Result Updates
30 October 2024 - Vilin Bio Med Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Outcome of Board Meeting
30 October 2024 - Vilin Bio Med Limited has informed regarding Board meeting held on October 30, 2024.
-
Board Meeting Intimation
23 October 2024 - VILIN BIO MED LIMITED has informed about Board Meeting to be held on 30-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the …
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
19 October 2024 - Vilin Bio Med Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
Business Overview:[1][2]
VBML is an ISO-9001-2008 & GMP certified manufacturer of Pharmaceutical formulations' viz. Oral Liquid (Syrups/Suspensions/Dry Powders (βeta & Non βeta-Lactam), Tablets & Capsules (βeta & Non βeta-Lactam), External Preparations, etc. It sells its products in bulk to Pharmaceuticals Manufacturers, Marketers and Traders. Company does not sell products under any brand name